• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2重组体:XBF与其亲本谱系之间的基因组比较。

SARS-CoV-2 Recombinants: Genomic Comparison between XBF and Its Parental Lineages.

作者信息

Scarpa Fabio, Locci Chiara, Azzena Ilenia, Casu Marco, Fiori Pier Luigi, Ciccozzi Alessandra, Giovanetti Marta, Quaranta Miriana, Ceccarelli Giancarlo, Pascarella Stefano, Ciccozzi Massimo, Sanna Daria

机构信息

Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.

Department of Veterinary Medicine, University of Sassari, 07100 Sassari, Italy.

出版信息

Microorganisms. 2023 Jul 17;11(7):1824. doi: 10.3390/microorganisms11071824.

DOI:10.3390/microorganisms11071824
PMID:37512996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10383834/
Abstract

Recombination events are very common and represent one of the primary drivers of RNA virus evolution. The XBF SARS-CoV-2 lineage is one of the most recently generated recombinants during the COVID-19 pandemic. It is a recombinant of BA.5.2.3 and BA.2.75.3, both descendants of lineages that caused many concerns (BA.5 and BA.2.75, respectively). Here, we performed a genomic survey focused on comparing the recombinant XBF with its parental lineages to provide a comprehensive assessment of the evolutionary potential, epidemiological trajectory, and potential risks. Genetic analyses indicated that although XBF initially showed the typical expansion depicted by a steep curve, causing several concerns, currently there is no indication of significant expansion potential or a contagion rate surpassing that of other currently active or previously prevalent lineages. BSP indicated that the peak has been reached around 19 October 2022 and then the genetic variability suffered slight oscillations until early 5 March 2023 when the population size reduced for the last time starting its last plateau that is still lasting. Structural analyses confirmed its reduced potential, also indicating that properties of NTDs and RBDs of XBF and its parental lineages present no significant difference. Of course, cautionary measures must still be taken and genome-based monitoring remains the best tool for detecting any important changes in viral genome composition.

摘要

重组事件非常普遍,是RNA病毒进化的主要驱动因素之一。XBF新冠病毒谱系是新冠疫情期间最新产生的重组毒株之一。它是BA.5.2.3和BA.2.75.3的重组体,而这两个谱系(分别为BA.5和BA.2.75)的后代曾引发诸多担忧。在此,我们开展了一项基因组调查,重点是将重组的XBF与其亲本谱系进行比较,以全面评估其进化潜力、流行病学轨迹和潜在风险。基因分析表明,尽管XBF最初呈现出典型的陡峭曲线式扩张,引发了一些担忧,但目前没有迹象表明其有显著的扩张潜力或传播率超过其他当前活跃或先前流行的谱系。贝叶斯天际线图分析表明,在2022年10月19日左右达到峰值,随后遗传变异性出现轻微波动,直到2023年3月5日早些时候种群规模最后一次下降,开始其仍在持续的最后一个平稳期。结构分析证实了其较低的潜力,还表明XBF及其亲本谱系的NTDs和RBDs特性没有显著差异。当然,仍必须采取预防措施,基于基因组的监测仍然是检测病毒基因组组成任何重要变化的最佳工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/10383834/1338e5d9ff9d/microorganisms-11-01824-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/10383834/522c907cfc78/microorganisms-11-01824-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/10383834/9a8018ebe8ea/microorganisms-11-01824-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/10383834/7a2c12cff8d9/microorganisms-11-01824-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/10383834/99d1c2aefecb/microorganisms-11-01824-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/10383834/f8ed7b8edc28/microorganisms-11-01824-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/10383834/1338e5d9ff9d/microorganisms-11-01824-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/10383834/522c907cfc78/microorganisms-11-01824-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/10383834/9a8018ebe8ea/microorganisms-11-01824-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/10383834/7a2c12cff8d9/microorganisms-11-01824-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/10383834/99d1c2aefecb/microorganisms-11-01824-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/10383834/f8ed7b8edc28/microorganisms-11-01824-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/10383834/1338e5d9ff9d/microorganisms-11-01824-g006.jpg

相似文献

1
SARS-CoV-2 Recombinants: Genomic Comparison between XBF and Its Parental Lineages.严重急性呼吸综合征冠状病毒2重组体:XBF与其亲本谱系之间的基因组比较。
Microorganisms. 2023 Jul 17;11(7):1824. doi: 10.3390/microorganisms11071824.
2
Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages.基于基因组的重组严重急性呼吸综合征冠状病毒2(SARS-CoV-2)XBB与其亲本谱系之间的比较。
J Med Virol. 2023 Mar;95(3):e28625. doi: 10.1002/jmv.28625.
3
Unraveling the genetic evolution of SARS-CoV-2 Recombinants using mutational dynamics across the different lineages.利用不同谱系间的突变动态解析新冠病毒重组体的遗传进化。
Front Med (Lausanne). 2024 Jan 15;10:1294699. doi: 10.3389/fmed.2023.1294699. eCollection 2023.
4
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level.面对人群水平抗体广度的成熟,BQ、BA.2.75 和 SARS-CoV-2 重组亚谱系的出现和抗体逃逸。
EBioMedicine. 2023 Apr;90:104545. doi: 10.1016/j.ebiom.2023.104545. Epub 2023 Mar 30.
5
Integrative Genome-Based Survey of the SARS-CoV-2 Omicron XBB.1.16 Variant.基于整合基因组的 SARS-CoV-2 奥密克戎 XBB.1.16 变体调查。
Int J Mol Sci. 2023 Sep 1;24(17):13573. doi: 10.3390/ijms241713573.
6
Incipient Parallel Evolution of SARS-CoV-2 Deltacron Variant in South Brazil.巴西南部出现新冠病毒“德尔塔克戎”变体的平行进化初期情况。
Vaccines (Basel). 2023 Jan 18;11(2):212. doi: 10.3390/vaccines11020212.
7
Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022.2021 年 5 月至 2022 年 1 月期间布隆迪严重急性呼吸综合征冠状病毒 2 的基因组监测。
BMC Genomics. 2023 Jun 10;24(1):312. doi: 10.1186/s12864-023-09420-3.
8
Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.追踪 SARS-CoV-2 奥密克戎多样化的刺突基因突变,鉴定出多个变异株间重组事件。
Signal Transduct Target Ther. 2022 Apr 26;7(1):138. doi: 10.1038/s41392-022-00992-2.
9
Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5.关于新冠病毒XBB.1.5流行病学传播的分子深度研究
Microorganisms. 2023 Mar 31;11(4):912. doi: 10.3390/microorganisms11040912.
10
Novel recombinant SARS-CoV-2 lineage detected through genomic surveillance in Wales, UK.英国威尔士通过基因组监测发现新型 SARS-CoV-2 谱系。
Microb Genom. 2023 Apr;9(4). doi: 10.1099/mgen.0.000984.

引用本文的文献

1
SARS-CoV-2 XEC: A Genome-Based Survey.严重急性呼吸综合征冠状病毒2型XEC:一项基于基因组的调查。
Microorganisms. 2025 Jan 24;13(2):253. doi: 10.3390/microorganisms13020253.
2
Update of the Genetic Variability of Monkeypox Virus Clade IIb Lineage B.1.猴痘病毒IIb分支B.1的遗传变异性更新
Microorganisms. 2024 Sep 11;12(9):1874. doi: 10.3390/microorganisms12091874.
3
Surfing the Waves of SARS-CoV-2: Analysis of Viral Genome Variants Using an NGS Survey in Verona, Italy.追踪新冠病毒的变异浪潮:利用下一代测序技术对意大利维罗纳地区的病毒基因组变异进行分析

本文引用的文献

1
SARS-CoV CH.1.1 Variant: Genomic and Structural Insight.严重急性呼吸综合征冠状病毒CH.1.1变异株:基因组与结构解析
Infect Dis Rep. 2023 May 24;15(3):292-298. doi: 10.3390/idr15030029.
2
Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5.关于新冠病毒XBB.1.5流行病学传播的分子深度研究
Microorganisms. 2023 Mar 31;11(4):912. doi: 10.3390/microorganisms11040912.
3
Genome-based survey of the SARS-CoV-2 BF.7 variant from Asia.基于基因组的亚洲新冠病毒BF.7变异株调查。
Microorganisms. 2024 Apr 24;12(5):846. doi: 10.3390/microorganisms12050846.
4
Integrative Genome-Based Survey of the SARS-CoV-2 Omicron XBB.1.16 Variant.基于整合基因组的 SARS-CoV-2 奥密克戎 XBB.1.16 变体调查。
Int J Mol Sci. 2023 Sep 1;24(17):13573. doi: 10.3390/ijms241713573.
5
Early Detection of the Recombinant SARS-CoV-2 XAN Variant in Bulgaria: Initial Genomic Insights into Yet Another Piece of the Growing Puzzle of Recombinant Clades.保加利亚对重组严重急性呼吸综合征冠状病毒2型XAN变体的早期检测:对重组分支这一日益复杂难题的又一部分的初步基因组见解。
Microorganisms. 2023 Aug 9;11(8):2041. doi: 10.3390/microorganisms11082041.
J Med Virol. 2023 Apr;95(4):e28714. doi: 10.1002/jmv.28714.
4
Genetic and structural genome-based survey reveals the low potential for epidemiological expansion of the SARS-CoV-2 XBB.1.5 sublineage.基于基因和结构基因组的调查揭示了新冠病毒XBB.1.5亚谱系在流行病学上的低传播潜力。
J Infect. 2023 Jun;86(6):596-598. doi: 10.1016/j.jinf.2023.02.039. Epub 2023 Mar 1.
5
Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages.基于基因组的重组严重急性呼吸综合征冠状病毒2(SARS-CoV-2)XBB与其亲本谱系之间的比较。
J Med Virol. 2023 Mar;95(3):e28625. doi: 10.1002/jmv.28625.
6
Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations.暴发信息基因组报告:可扩展和动态监测 SARS-CoV-2 变体和突变。
Nat Methods. 2023 Apr;20(4):512-522. doi: 10.1038/s41592-023-01769-3. Epub 2023 Feb 23.
7
Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants.在 SARS-CoV-2 变异株中,普遍存在且免疫优势的 CD8 T 细胞表位是保守的。
Cell Rep. 2023 Jan 31;42(1):111995. doi: 10.1016/j.celrep.2023.111995. Epub 2023 Jan 9.
8
Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion.SARS-CoV-2 奥密克戎 BQ.1 变体的遗传和结构数据表明其在流行病学上的扩展潜力较低。
Int J Mol Sci. 2022 Dec 3;23(23):15264. doi: 10.3390/ijms232315264.
9
Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB.奥密克戎亚变体BQ.1.1和XBB的体液免疫逃逸
Lancet Infect Dis. 2023 Jan;23(1):30-32. doi: 10.1016/S1473-3099(22)00816-7. Epub 2022 Dec 7.
10
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.抗病毒药物对奥密克戎亚型BQ.1.1和XBB的疗效
N Engl J Med. 2023 Jan 5;388(1):89-91. doi: 10.1056/NEJMc2214302. Epub 2022 Dec 7.